WINDLAS logo

Windlas Biotech Limited Stock Price

NSEI:WINDLAS Community·₹19.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

WINDLAS Share Price Performance

₹937.75
-96.45 (-9.33%)
₹937.75
-96.45 (-9.33%)
Price ₹937.75

WINDLAS Community Narratives

There are no narratives available yet.

Snowflake Analysis

Flawless balance sheet second-rate dividend payer.

1 Risk
2 Rewards

Windlas Biotech Limited Key Details

₹7.9b

Revenue

₹5.0b

Cost of Revenue

₹3.0b

Gross Profit

₹2.3b

Other Expenses

₹651.8m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Nov 06, 2025
31.10
37.71%
8.20%
6.4%
View Full Analysis

About WINDLAS

Founded
2001
Employees
1346
CEO
Komal Gupta
WebsiteView website
windlas.com

Windlas Biotech Limited, a contract development and manufacturing organization, manufactures and trades in pharmaceutical products in India. The company offers contract manufacturing; customized formulations; contract research and manufacturing services; customized formulation; and regulatory services. It also manufactures tablets, capsules, oral solids, modified-release formulations, chewable and dispersible tablets, customized generics, and complex generics and multi-drug combinations, as well as injectables, including liquid vials, lyophilized vials, and ampoules. In addition, the company offers generic drugs for respiratory, anti-diabetic, gastroenterology, cardiovascular and multivitamin, neuro anti-psychotic, diabetic care, nutraceuticals, nutritional supplement, urology, pain management, and injectable therapies. It also exports generic medicines, health supplements, and custom-branded formulations. Windlas Biotech Limited was incorporated in 2001 and is headquartered in Dehradun, India.

Recent WINDLAS News & Updates

Recent updates

No updates